NEW YORK (Reuters) – Moderna Inc’s top scientist said on Tuesday that the vaccine maker has learned how to better recruit from diverse populations for its clinical trials from running its COVID-19...

Axial spondyloarthritis sufferer shares his story We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us...

LONDON (Reuters) – The number of people in Europe with undiagnosed HIV has risen as testing rates fell during the COVID-19 pandemic, threatening a global goal of ending the disease by 2030, a report...

Medtronic has issued a recall of the controller driveline cover of the company’s HeartWare Ventricular Assist Device (HVAD) system. The Medtronic HVAD system was approved as a bridge to heart transplantation...

Stories about how daily stress can negatively impact people’s lives, from physical health to mental and emotional well-being, are frequently in the media. But there is good news about the experience...

“In Germany, a patient dies every 20 minutes from mostly vascular-related events caused by diabetes,” said Berthold Amann, MD, conference president of the German Society for Angiology (DGA)....

Medication that helps reduce a person’s risk of developing cardiovascular and kidney disease is a cost-effective option to treat Australia’s entire population of people with type 2 diabetes,...

The formation of amyloid plaques in the brain is a hallmark of Alzheimer’s disease. But drugs designed to reduce accumulations of these plaques have so far yielded, at best, mixed results in clinical...

In a recent study published in the Journal of Global Antimicrobial Resistance, researchers comparatively evaluated trends in antimicrobial resistance (AMR) among urinary Escherichia coli strains from...

insights from industryWaduda Parolari MusaidProduct SpecialistGloreha NewsMedical spoke to Waduda Parolari Musaid at MEDICA 2022 about Gloreha's robotics-assisted neurorehabilitation solutions....